Exact Mass: 478.1263762
Exact Mass Matches: 478.1263762
Found 29 metabolites which its exact mass value is equals to given mass value 478.1263762,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Lappaphen A
C27H26O4S2 (478.12724360000004)
Lappaphen b belongs to guaianolides and derivatives class of compounds. Those are diterpene lactones with a structure characterized by the presence of a gamma-lactone fused to a guaiane, forming 3,6,9-trimethyl-azuleno[4,5-b]furan-2-one or a derivative. Lappaphen b is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Lappaphen b can be found in burdock, which makes lappaphen b a potential biomarker for the consumption of this food product.
(3-[3-hydroxy-5-methoxyphenyl]-5-methoxy-7-oxo-3,7-dihydro-2H-[1,4]dioxino[2,3-c]xanthen-2-yl)methyl acetate|hypericorin A
11-O-beta-D-glucopyranosyloxy-5-methoxy-6-oxabenzochrysen-1-one|haemodoroxychrysenose
beta-D-glucopyranosyl-(6->1)-beta-D-rhamnosyl 3,4,5-trihydroxybenzoate
2,5-Bis-(beta-D-glucopyranosyloxy)-benzoesaeure|Gentisat-2,5-di-beta-D-glucosid
Asp Asp Asp Asp
GW 590735
C23H21F3N2O4S (478.11740620000006)
BRL-15572
BRL-15572 dihydrochloride is a selective antagonist of h5-HT1D, displays high affinity for h5-HT1D receptors. BRL-15572 dihydrochloride could be useful pharmacological agents to characterise 5-HT1D receptor mediated responses[1].
1,5-Bis(2-carboxyanilino)anthraquinone
Beigene-283
C25H17F3N4O3 (478.12526879999996)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2336 - Raf Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor Lifirafenib (BGB-283) is a novel and potent Raf Kinase and EGFR inhibitor with IC50 values of 23 and 29 nM for recombinant BRafV600E and EGFR, respectively.
2-Methyl-2-(4-((4-methyl-2-(4-(trifluoromethyl)phenyl)thiazole-5-carboxamido)methyl)phenoxy)propanoic acid
C23H21F3N2O4S (478.11740620000006)
6-ethyl-2-[(4-morpholin-4-ylsulfonylbenzoyl)amino]-5,7-dihydro-4H-thieno[2,3-c]pyridine-3-carboxamide
(2S)-2-azaniumyl-5-({(2R)-1-[(carboxylatomethyl)amino]-3-[(1,4-dihydroxy-3-methylnaphthalen-2-yl)sulfanyl]-1-oxopropan-2-yl}amino)-5-oxopentanoate
2-methyl-5-[(2-oxo-1H-benzo[cd]indol-6-yl)sulfonylamino]-3-benzofurancarboxylic acid butyl ester
N-[(5-chloro-8-hydroxy-7-quinolinyl)-(3,4-dimethoxyphenyl)methyl]-4-methoxybenzamide
N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[[4-(2-furanylmethyl)-5-(phenoxymethyl)-1,2,4-triazol-3-yl]thio]acetamide
C24H22N4O5S (478.13108420000003)
DM-4103
A 4-oxo monocarboxylic acid that is 4-oxobutanoic acid substituted at position 4 with a 5-chloro-2-[2-methyl-4-(2-methylbenzamido)benzamido]phenyl group. An oxobutyric acid metabolite of the vasopressin V2-receptor antagonist tolvaptan.